StockClub

Latest News

MacroCNBC

Economic outlook is worsening and Trump is getting blamed, CNBC survey finds

Americans remain deeply concerned about their financial future despite a surging stock market and lower gas prices, the latest CNBC All-America Economic Survey. Amid the angst over rising prices for f

3 months ago
DividendPRNewsWire

Solstice Advanced Materials Declares Dividend of $0.075 per Common Share

MORRIS PLAINS, N.J., July 17, 2026 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS), today announced that its Board of Directors has declared a regular quarterly dividend payment of seven an

3 months ago
MacroCNBC

U.S.-China AI feud sees ASML walk tightrope between sales and geopolitics

China will contribute around 20% of ASML's revenue across the whole of 2026, the company's CFO said. While that figure is a sizable drop from previous years, political headwinds in the U.S. are pushin

3 months ago
AnalystProactive Investors

American bank says Ryanair's share price weakness has run too far

Citi has argued that Ryanair Holdings PLC's (LSE:RYA) recent underperformance against Europe's legacy airlines is overdone and looks set to reverse. The bank said shares in the Irish low-cost carrier

3 months ago
AnalystSeeking Alpha

Webull: Why The Bear Case Is Louder Than It Should Be

Webull has been upgraded from Hold to Buy after a 35% stock decline and notable multiple compression. BULL's consistent revenue beats since IPO reinforce confidence in management and the company's gro

3 months ago
OtherPRNewsWire

REGENXBIO Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants

ROCKVILLE, Md., July 17, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the pricing of an underwritten public offering of 10,003,889 shares of its common stock at the price of $9.0

3 months ago
ProductGlobeNewsWire

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

Data from the expanded cohorts reinforce the positive BCVA, OCT, pharmacokinetic and time-to-retreatment findings observed in the original cohorts

3 months ago
Sponsored
OtherGlobeNewsWire

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

BrewDog and Tilray are keeping football's biggest celebration alive by unlocking the £1 million bar tab at participating pubs 1 beginning July 20 because great football deserves celebrating, no matter

3 months ago
EarningsGlobeNewsWire

Ridgepost Capital to Announce Second Quarter 2026 Financial Results and Host Investor Call

DALLAS, July 17, 2026 (GLOBE NEWSWIRE) -- Ridgepost Capital, Inc. (NYSE: RPC) (“Ridgepost Capital” or the “Company”), a leading private markets solutions provider, today announced it will release fina

3 months ago
OtherNewsfile Corp

Cybeats Announces Non-Brokered Private Placement

Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Cybeats Technologies Corp. (CSE: CYBT) (OTCQB: CYBCF) ("Cybeats" or the "Company"), a leading provider of software supply-chain security, announces

3 months ago
EarningsGlobeNewsWire

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to revi

3 months ago
EarningsPRNewsWire

MSC Income Fund Announces Second Quarter 2026 Earnings Release and Conference Call Schedule

Call Scheduled for 11:00 a.m. Eastern Time on Friday, August 7, 2026 HOUSTON, July 17, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE: MSIF) ("MSC Income" or the "Fund") is pleased to announce that

3 months ago
EarningsPRNewsWire

Solstice Advanced Materials to Announce Second Quarter 2026 Financial Results on July 30, 2026

MORRIS PLAINS, N.J., July 17, 2026 /PRNewswire/ -- Solstice Advanced Materials (NASDAQ: SOLS) ("Solstice" or "the Company") will issue its second quarter financial results before market open on July 3

3 months ago
OtherGlobeNewsWire

MoonFox Alternative Data Expands Offline Foot Traffic Coverage to Leading China and Global Stocks

SHENZHEN, China, July 17, 2026 (GLOBE NEWSWIRE) -- MoonFox Data, China's leading alternative data provider, is proud to announce a major expansion of its offline (foot traffic) data coverage, now trac

3 months ago
Sponsored
OtherGlobeNewsWire

Click Holdings Limited (CLIK) Surpasses 6 Million Senior Care Hours; Unveils Global ESG Framework to Power International and Mainland China Expansion

Hong Kong, July 17, 2026 (GLOBE NEWSWIRE) -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human re

3 months ago
M&APYMNTS

PayPal Board Calls $53 Billion Stripe-Advent Bid Inadequate

PayPal's board believes the $53 billion takeover offer from Stripe and Advent International offered on July 15 undervalues the company. According to a report from Reuters, the development could potent

3 months ago
EarningsSeeking Alpha

Wall Street Breakfast Podcast: Starship Stall Weighs On SpaceX

SpaceX (SPCX) fell 4.2% after aborting its Starship V3 launch, extending a five-day losing streak below its $135 IPO price. Netflix (NFLX) missed Q2 revenue expectations at $12.56B, despite 13.4% Y/Y

3 months ago
EarningsGlobeNewsWire

CrossAmerica Partners to Announce Second Quarter 2026 Earnings Results on August 5

Allentown, PA, July 17, 2026 (GLOBE NEWSWIRE) -- CrossAmerica Partners to Announce Second Quarter 2026 Earnings Results on August 5 ALLENTOWN, PA, July 17, 2026 – CrossAmerica Partners LP (NYSE: CAPL)

3 months ago
EarningsBenzinga

AMC Entertainment Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

AMC Entertainment Holdings, Inc. (NYSE:AMC) will release its second quarter earnings report before the opening bell on Monday, July 20.

3 months ago
OtherSeeking Alpha

Inhibrx Biosciences: The Rare Disease Launch Is Only The Opening Act

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers. Ozekibart's BLA for chondrosarcoma is under FDA review with an April 14, 2027 P

3 months ago